Therefore, we tested the expression levels of Bcl-2 and Bax in the ovarian cancer tissues from cisplatin-resistant/sensitive patients by Western blot assay and calculated the ratio of Bax/Bcl-2. The gene discussed is BAX; the disease is ovarian cancer.